Lithium Carbonate Tablet, Extended Release
Product Images NDC 0054-0020

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 0054-0020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fpl-bl-450mg-100tabs-04.jpg (Fpl Bl 450mg 100tabs 04)

This is a medication prescription for Lithium Carbonate Extended-release Tablets USP containing 450mg. The recommended dosage is not included hence referring to the package insert for complete prescribing information. The medication should be stored in a tightly closed child-resistant container at a temperature of between 20 to 25 degrees Celsius and protected from moisture. The package contains 100 tablets distributed by West-Ward Pharmaceuticals with a warning that is included in the package insert. The rest of the text is not available due to errors.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.